A detailed history of Israel Englander (Millennium Management LLC) transactions in Astrazeneca PLC stock. As of the latest transaction made, Millennium Management LLC holds 172,900 shares of AZN stock, worth $11.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
172,900
Previous 381,100 54.63%
Holding current value
$11.3 Million
Previous $29.7 Million 54.67%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $6.58 Million - $7.52 Million
85,829 Added 262.9%
118,476 $9.23 Million
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $191 Million - $231 Million
-2,860,462 Reduced 98.87%
32,647 $2.55 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $139 Million - $159 Million
2,280,041 Added 371.91%
2,893,109 $196 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $12.7 Million - $14.2 Million
205,663 Added 50.48%
613,068 $41.3 Million
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $28.3 Million - $30.7 Million
404,349 Added 13231.32%
407,405 $29.2 Million
Q1 2023

May 15, 2023

SELL
$63.15 - $71.6 $39.7 Million - $45 Million
-628,006 Reduced 99.52%
3,056 $212,000
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $43.4 Million - $56.3 Million
-799,799 Reduced 55.9%
631,062 $42.8 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $14.4 Million - $36.8 Million
271,089 Added 23.37%
1,430,861 $78.5 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $47.9 Million - $57.5 Million
807,966 Added 229.66%
1,159,772 $76.6 Million
Q1 2022

May 16, 2022

SELL
$55.72 - $67.12 $21.2 Million - $25.5 Million
-380,107 Reduced 51.93%
351,806 $23.3 Million
Q4 2021

Feb 14, 2022

BUY
$54.02 - $63.83 $11.5 Million - $13.6 Million
212,942 Added 41.03%
731,913 $42.6 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $26.6 Million - $29.2 Million
479,578 Added 1217.42%
518,971 $31.2 Million
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $4.26 Million - $5.3 Million
-87,999 Reduced 69.08%
39,393 $2.36 Million
Q1 2021

May 17, 2021

BUY
$47.16 - $54.44 $5.1 Million - $5.89 Million
108,171 Added 562.78%
127,392 $6.33 Million
Q4 2020

Feb 16, 2021

SELL
$48.52 - $58.02 $8.97 Million - $10.7 Million
-184,950 Reduced 90.59%
19,221 $961,000
Q3 2020

Nov 16, 2020

SELL
$53.07 - $61.1 $3.29 Million - $3.78 Million
-61,921 Reduced 23.27%
204,171 $11.2 Million
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $11.5 Million - $14.7 Million
266,092 New
266,092 $14.1 Million
Q1 2020

May 14, 2020

SELL
$37.79 - $51.33 $13.9 Million - $18.8 Million
-367,096 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$42.46 - $50.46 $15 Million - $17.8 Million
352,489 Added 2413.15%
367,096 $18.3 Million
Q3 2019

Nov 14, 2019

SELL
$40.12 - $45.47 $24 Million - $27.2 Million
-598,871 Reduced 97.62%
14,607 $651,000
Q2 2019

Aug 15, 2019

SELL
$37.28 - $41.68 $2.95 Million - $3.3 Million
-79,254 Reduced 11.44%
613,478 $25.3 Million
Q2 2019

Aug 14, 2019

SELL
$37.28 - $41.68 $23 Million - $25.8 Million
-618,266 Reduced 47.16%
692,732 $31.5 Million
Q1 2019

May 14, 2019

BUY
$35.49 - $43.02 $46.1 Million - $55.9 Million
1,299,717 Added 11521.29%
1,310,998 $53 Million
Q4 2018

Feb 14, 2019

SELL
$36.86 - $41.49 $29 Million - $32.7 Million
-787,267 Reduced 98.59%
11,281 $428,000
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $1.58 Million - $1.8 Million
-45,376 Reduced 5.38%
798,548 $31.6 Million
Q2 2018

Aug 14, 2018

SELL
$34.55 - $37.05 $45.2 Million - $48.5 Million
-1,308,838 Reduced 60.8%
843,924 $29.6 Million
Q1 2018

May 15, 2018

BUY
$32.97 - $36.63 $24.8 Million - $27.5 Million
751,610 Added 53.64%
2,152,762 $75.3 Million
Q4 2017

Feb 14, 2018

SELL
$32.09 - $34.78 $13.7 Million - $14.8 Million
-425,581 Reduced 23.3%
1,401,152 $48.6 Million
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $52.9 Million - $62.1 Million
1,826,733
1,826,733 $61.9 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.